A group of chimpanzees, formerly subjects in hepatitis B vaccine research, are currently undergoing comprehensive health screenings at a sanctuary in Liberia. The assessments are part of an ongoing commitment to provide long-term care for the primates following their retirement from laboratory settings.

While the report confirms the animals are receiving medical attention, it does not detail the specific health outcomes or the current population size of the group under care. The focus remains on the transition from experimental environments to sanctuary life, highlighting the logistical efforts required to maintain the well-being of primates that were once used for human medical advancement. The report does not address the broader ethical debate surrounding the use of chimpanzees in medical research, nor does it provide input from the organizations that previously conducted the experiments. The current status of the sanctuary’s funding and the long-term sustainability of the care program remain unaddressed in the available reporting.